Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Bagel

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Academy of Dermatology|December 15, 2022
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohortKatrina Abuabara, Lawrence F Eichenfield, Robert Bissonnette, et al.
JAMA Dermatology|May 7, 2025
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical TrialMelinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
Dermatology and Therapy|January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt StudyJonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
JAMA Dermatology|June 22, 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic ReviewAdam R Ford, Michael Siegel, Jerry Bagel, et al.
JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
The New England Journal of Medicine|October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, et al.
Journal of the American Academy of Dermatology|December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasisApril W Armstrong, Michael P Siegel, Jerry Bagel, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Academy of Dermatology|December 15, 2022
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohortKatrina Abuabara, Lawrence F Eichenfield, Robert Bissonnette, et al.
JAMA Dermatology|May 7, 2025
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical TrialMelinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
Dermatology and Therapy|January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt StudyJonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
JAMA Dermatology|June 22, 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic ReviewAdam R Ford, Michael Siegel, Jerry Bagel, et al.
JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
The New England Journal of Medicine|October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, et al.
Journal of the American Academy of Dermatology|December 3, 2016
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasisApril W Armstrong, Michael P Siegel, Jerry Bagel, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
Pageof 10